A critical assessment of oxaprozin clinical profile in rheumatic diseases

Author： Kean Walter F.   Kean Robert   Buchanan W. Watson  

Publisher： VSP

ISSN： 1568-5608

Source： Inflammopharmacology, Vol.10, Iss.3, 2002-08, pp. : 241-284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacokinetics of Oxaprozin

By Davies N.M.  

Clinical Pharmacokinetics, Vol. 35, Iss. 6, 1998-12 ,pp. : 425-436

Adis International

Access to resources Recommend Favorite

Assessment of Thyroid Disorders and Autoimmunity in Patients with Rheumatic Diseases

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 14, Iss. 3, 2014-09 ,pp. : 182-186

Bentham Science Publishers

Access to resources Recommend Favorite

A review of the emerging profile of the anti-inflammatory drug oxaprozin

By Dallegri Franco   Bertolotto Maria   Ottonello Luciano  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 5, 2005-05 ,pp. : 777-785

Informa Healthcare

Access to resources Recommend Favorite

Chemokines in Rheumatic Diseases

By  

Current Drug Targets, Vol. 7, Iss. 1, 2006-01 ,pp. : 91-102

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Melatonin in Rheumatic Diseases

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 4, 2009-08 ,pp. : 453-456

Bentham Science Publishers

Access to resources Recommend Favorite